Comparison of Efficacy, Safety and Cost of Therapy with Oral Ferrous Ascorbate and Ferrous Sulphate in Patients with Iron Deficiency Anemia
Journal Title: Journal of Drug Discovery and Therapeutics - Year 2014, Vol 2, Issue 8
Abstract
Objective: To compare the efficacy and safety of oral ferrous ascorbate and ferrous sulphate in patients with iron deficiency anemiaMethods: An observational, prospective study in patients of anemia in chronic kidney disease (CKD) and pregnancy receiving oral ferrous ascorbate and ferrous sulfate respectively were included. Demographic details, clinical history, baseline hemoglobin, anemia indices data were recorded in a case record form. The patients were followed up monthly for 12 weeks and observed for clinical and hematological improvement and adverse drug reactions (ADRs). The data was analyzed using paired t-test, unpaired t-test and Fisher`s exact test.Results: Out of 148 anemic patients, 62 CKD patients received ferrous ascorbate and 86 pregnant patients treated with ferrous sulfate. Ferrous ascorbate and ferrous sulphate have significantly (P<0.0001) improved mean hemoglobin and anemia indices at the end of study, however, mean increase in hemoglobin was more and significant (P<0.000) with ferrous ascorbate (3.45 g/dL) as compared to ferrous sulfate (3.3 g/dL). Mean increase in MCV and MCHC were comparable in both ferrous ascorbate and ferrous sulfate treated patients, however, mean increase in MCH was significantly (P <0.005) with ferrous sulfate (4.7 pg/cell) treated patients as compared to ferrous ascorbate (3.15 pg/cell). ADRs were more in patients treated with ferrous sulfate (86%) than ferrous ascorbate (71%). Cost of therapy incurred to patient treated with ferrous ascorbate (Rs. 1269.6) was three time more as compared to ferrous sulfate (Rs. 409.7).Conclusion: Ferrous ascorbate and ferrous sulfate, both were effective and safe in treating iron deficiency anemia in patients with CKD and pregnancy respectively. However, ferrous ascorbate increased hemoglobin more, with better tolerated by patients. Unfortunately, cost of therapy with ferrous ascorbate was high as compared to ferrous sulfate.
Authors and Affiliations
Panchal Pavan J| MD Pharmacology, Department of Pharmacology, B. J. Medical College, Ahmedabad-380016, India, Desai Mira K| MD Pharmacology, Department of Pharmacology, B. J. Medical College, Ahmedabad-380016, India
Keywords
Related Articles
- EP ID EP1502
- DOI -
- Views 546
- Downloads 25
ARTEROLANE MALEATE AND PIPERAQUINE PHOSPHATE: A NEW OPTION IN THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA
Malaria is holoendemic in India, claiming thousands of deaths annually. Recent data suggests that the burden of malaria, the most significant parasitic disease in the world, is increasing. India’s expansive geography and...
PREPARATION AND EVALUATION OF NANOSUSPENSION OF POORLY SOLUBLE DRUG ALBENDAZOLE
The aim of the present work was to enhance solubility of albendazole a class II drug by nanosuspension technology. Nanosuspensions are prepared by using wet mill, high pressure homogenizer, emulsion‐solvent diffusion, me...
LARVICIDAL ACTIVITY OF HERBALS: A REVIEW
Mosquitoes are the important and major blood-sucking vectors and it transmits parasites and pathogens which cause devastating impact on human beings. The most common diseases associated with mosquitoes are dengue fev...
Synthesis, characterisation and invitro anticancer activity of thiazolidine-2,4-dione derivatives
Thiazolidine-2,4-diones exhibit broad spectrum of biological activities like antimicrobial, anticancer, anti-inflammatory, anti diabetic etc.The aim and objective of present study was to develop novel thiazolidine-2,4-di...
COMPREHENSIVE REVIEW ON PULSATILE DRUG DELIVERY SYSTEM
Oral controlled drug delivery systems represent the most popular form of controlled drug delivery systems for the obvious advantages of oral route of drug administration. However, there are certain conditions for which s...